JAK-STAT-IN-1

CAS No. 1236666-76-4

JAK-STAT-IN-1( —— )

Catalog No. M37203 CAS No. 1236666-76-4

JAK-STAT-IN-1 is a specific JAK-STAT inhibitor indicated for the study of autoimmune diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 459 Get Quote
10MG 657 Get Quote
25MG 994 Get Quote
50MG 1371 Get Quote
100MG 1773 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    JAK-STAT-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    JAK-STAT-IN-1 is a specific JAK-STAT inhibitor indicated for the study of autoimmune diseases.
  • Description
    JAK-STAT-IN-1 (compound 1) is a selective JAK-STAT inhibitor. JAK-STAT-IN-1 can be used for the research of autoimmune disorder.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    JAK
  • Recptor
    JAK | STAT
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1236666-76-4
  • Formula Weight
    375.42
  • Molecular Formula
    C21H21N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1OC2=CC=C(C=C2N1)NC3=NC(=NC=C3C)NC=4C=C(C(=C(C4)C)C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Llinas A , et al. Derisking Development by a Cocrystallization Screen of a Novel Selective Inhaled JAK-STAT inhibitor[J].Crystal Growth And Design, 2019, 19(1):403-414.
molnova catalog
related products
  • PF-06700841 tosylate

    PF-06700841 is a potent, selective TYK2/JAK1 kinase inhibitor that reduces IL-23 expression and directly attenuates IL-23 signaling via TYK2.

  • Decernotinib

    Decernotinib (VX-509, VRT-831509) is a potent, selective, orally available JAK3 inhibitor with Ki of 2.5 nM and cellular IC50 of 50-170 nM.

  • WYE-151650

    WYE-151650 is a novel potent, selective JAK3 inhibitor with IC50 of 0.8 nM, displays 36-, 14-, and 34-fold selectivity against JAK-1, JAK-2, and Tyk-2, respectively.